Navigation Links
In Pain Market, Huge Unmet Needs, Tough Regulatory Environment Challenge Pharmaceutical Companies, According to MedPredict
Date:6/23/2008

SCOTTSDALE, Ariz., June 23 /PRNewswire/ -- MedPredict has published a new report designed to provide critical strategic insight for pharma and biotech companies hoping to identify the next blockbuster drug for pain management. The report, entitled "Thought Leader Insight & Analysis: Pain/Analgesics," is based on in-depth interviews conducted with a panel of specialists in anesthesiology, psychiatry, rheumatology, gastroenterology and primary care.

The diagnosis and treatment of nociceptive, neuropathic and somatic pain varies considerably depending on the physician specialty. MedPredict's panelists in each specialty outline their therapeutic goals and unmet needs in treating pain associated with cancer, fibromyalgia, trauma, rheumatoid and osteoarthritis, back injury, neuropathy, depression, migraine and Crohn's disease.

"Pain is subjective," said Dr. Jeffrey Berk, MedPredict's president. "If you think that you hurt, you hurt. This subjectivity makes the diagnosis and treatment of pain exceedingly difficult, and it presents enormous challenges for researchers trying to demonstrate analgesic efficacy versus placebo." One path to success will be to narrowly define the population being studied, as Lilly has done with duloxatine in diabetic neuropathy, according to Dr. Berk.

MedPredict's panelists predict successes and failures in a number of therapeutic targets, including mu receptor agonists/opioids, serotonergic/noradrenergics, sodium and calcium channel blockers, NMDA/glutamate, Alpha-2 agonist, (mGlu2/3), acetylcholine, AMPA, cannabinoid, NF Kappa b, TRPV1/vanilloids, stimulants, NSAIDs, hyaluronic acid, anti-IL-10 and anti-IL-1. They evaluate the development pipeline based on the medical potential, mechanism of action, reimbursement and regulatory environment and relevance of Schedule II status.

Companies/Partnerships discussed in this report include Allergan, Allergan/Acadia, Alpharma, Alpharma/Institut Biochimique, Amgen, Amgen
'/>"/>

SOURCE MedPredict
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Having Penetrated Israels Domestic Telephony Market, 012 Smile.Communications Prepares for Its Next Goal: Entering Israels Cellular Market
2. CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL)
3. Unmet Needs Provide Challenges and Opportunities for Rheumatoid Arthritis Drug Developers According to MedPredict Report
4. Biotech Avoids Fall Out From Tough Quarter for Capital Markets
5. Bringing a New Rhythm to Cardiology Workflow: Siemens Demonstrates Answers to Cardiologys Toughest Questions
6. pH Balanced RepHresh Vaginal Gel(R) now Available to Women in Canada Attacking Tough, Embarrassing Feminine Issues
7. Biotech Drops Amid Tough Markets in February
8. ATS Medical Announces Canadian Regulatory Approval of the ATS Open Pivot AP360 Mechanical Heart Valve
9. Neuftec Responds to a Fundamental Inaccuracy in Oxonica PLCs Regulatory Announcement
10. PAREXEL Product Development and Regulatory Experts to Attend the 2008 BIO International Convention
11. European Regulatory Agency Supports OPAXIO(TM) Brand Name for Cell Therapeutics Lung Cancer Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)..., part of Life Technologies Corporation (NASDAQ:LI...h and discovery solutions, today announced that it... the SOLiD™ System, has been named the Life ...entist, a leading scientific publication focused o...ement of the first-ever Life Science Innovation of...
(Date:12/3/2008)...nd secondhand smoke, an estimated ten percent of p...f a developing baby to harmful cigarette byproduct...000 newborns each year and poses a significant hea...s kind, a team of researchers has completed a glob... better understand the fetal health risks from smo...
(Date:12/3/2008)...FirstCall/ -- GlaxoSmithKline,(LSE/NYSE: GSK ) ...ating to a,pending lawsuit in the previously anno...ding shares of common stock of Genelabs Technologi...n cash without interest and less any,required wit...completion of the tender offer that there not be,...
(Date:12/3/2008)...-- Cellectricon, a leading,provider of screening ...,signing of a collaborative agreement with The Aut...s of advanced automated systems for cell culture, ...pplications. Under the agreement,TAP will co-deve...ectricon,s,next generation high throughput ion ch...
Breaking Biology Technology: Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 2 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 3 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 4 Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research 5Cutting the cord to determine babies' health risk from toxic exposure 2Cutting the cord to determine babies' health risk from toxic exposure 3Cutting the cord to determine babies' health risk from toxic exposure 4GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 2GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 3Cellectricon Partners With The Automation Partnership - Bringing Next Generation Ion Channel Screening System to Market. 2Cellectricon Partners With The Automation Partnership - Bringing Next Generation Ion Channel Screening System to Market. 3
...ely following the progress of the Health Insuranc...electronic health records for the last eight month... dentist with a small healthcare business, I have ...all a "stakeholder" in this exciting and promising...re important than my job, I am a husband and fathe...
...- BellBrook Labs has been awarded two federal gran...opment of its enzyme screening product. , ,The bio... screening tools for the drug-therapy market, said...l Business Innovation Research (SBIR) awards. Hig...ct millions of biochemical, genetic, or pharmacolo...
...- An education research team at the University of...he MacArthur Foundation to study the impact of d...acy. , ,MacArthur,s total $50 million investment ...cts of the digital revolution and its educational ...actually trying to do, with this grant to us, is e...
...eek in Austin , Dallas , and Boston , getting a...art ups. (Yep, you guessed it, the search for DEMO...h of what I saw was quite impressive. It was also ...lley . , ,Where Silicon Valley is at the apex of ...dership in IT systems management. In Dallas, I fou...
Other Biology Technology:Careful with that electronic health record, Mr. Leavitt 2Careful with that electronic health record, Mr. Leavitt 3Careful with that electronic health record, Mr. Leavitt 4Grants worth $800,000 help BellBrook Labs develop products 2UW gets $3M to explore educational gaming 2UW gets $3M to explore educational gaming 3What makes Silicon Valley so different? 2What makes Silicon Valley so different? 3What makes Silicon Valley so different? 4
(Date:12/4/2008)...en want younger women, often touting their intelli...earch at Gothenburg University and Oxford Universi...en and women choose partners. , Research in the ...theories about how men and women choose their part... place more emphasis on attractive appearance, whe...
(Date:12/3/2008)...nes, deputy executive director of the Internationa...tlook 2008" Dec. 9 at Rice University,s Baker Inst...ch questions as: Is the world facing a supply crun...at type of post-Kyoto policy framework might stabi... and what impact might such a policy framework hav...
(Date:12/3/2008)...re. December 3, 2008. The first 5-year forest inve... is now available to the public: Oregon,s Forest R...d Analysis Report. , Here are some key findings ... 30 million acres; about half of Oregon,s total la...ng converted to other uses particularly near urban...
(Date:12/3/2008)...-- A Duke University study suggests that evolution... the dogs depend on an energy-efficient style of f...eir prey, cats seem to have evolved a profoundly i...e or bird in slow motion. , "It is usually assum...said Daniel Schmitt, a Duke associate professor of...
Breaking Biology News(10 mins):Myth about 'dirty old men' supported by science 2'World Energy Outlook' to be presented at Rice University Dec. 9 2Forest inventories in Oregon include more than trees 2Forest inventories in Oregon include more than trees 3Dogs chase efficiently, but cats skulk counterintuitively 2Some Iraq War Vets Suffer Breathing Problems 19978 1Some Iraq War Vets Suffer Breathing Problems 19978 2Some Iraq War Vets Suffer Breathing Problems 19978 3Emerging Capital Partners Invests 2447 3 Million in North African Personal Care Company 19973 1Emerging Capital Partners Invests 2447 3 Million in North African Personal Care Company 19973 2FDA Accepts Zingo 28TM 29 Supplemental New Drug Application to Reduce Pain Associated With Peripheral Needle Insertion Procedures in Adults 5547 1FDA Accepts Zingo 28TM 29 Supplemental New Drug Application to Reduce Pain Associated With Peripheral Needle Insertion Procedures in Adults 5547 2FDA Accepts Zingo 28TM 29 Supplemental New Drug Application to Reduce Pain Associated With Peripheral Needle Insertion Procedures in Adults 5547 3FDA Accepts Zingo 28TM 29 Supplemental New Drug Application to Reduce Pain Associated With Peripheral Needle Insertion Procedures in Adults 5547 4Low intensity case management cuts COPD related hospital visits in half 19966 1Low intensity case management cuts COPD related hospital visits in half 19966 2
...omparison of equipment that can analyze the expres...etic "fingerprint," suggests these different micro...t. , Published in the May 2005 issue of Nature Me... of information generated by these systems might a...systems are used by many different laboratories. ,...
...he University of Liverpool have discovered how the...f Europeans resistant to HIV. Scientists have know...etic mutation (known as CCR5-delta32) that prevent...system but have been unable to account for the hig... low levels in areas bordering the Mediterranean. ...
...of North Carolina at Chapel Hill is one of five cl...e National Institutes of Health to study why good ...ring the next seven years, the Drug-Induced Liver ...have suffered severe liver injury caused by prescr...al supplements, alternative medicines and herbals....
... microarray analyses result in many differentially...for the biological process of interest. In order t...publications from MEDLINE were identified in which... with specific keywords were co-mentioned. , MEDLI... keywords were generated and validated. PubMed IDs...
Other Biology News:Different microarray systems more alike than previously thought 2Different microarray systems more alike than previously thought 3First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes 2UNC launches study of liver injury caused by drugs 2
MOUSE ANTI HUMAN MBP (67-74) Immunogen: Human myelin basic protein
MOUSE ANTI BOVINE TROPONIN I
Ready-to-use; 40mg/ml X-Gal and 32mg/ml IPTG
Normal donkey serum collected from healthy normal donkeys.
Biology Products: